202 related articles for article (PubMed ID: 32959228)
1. A key role for conservative treatment in the management of pituitary apoplexy.
Marx C; Rabilloud M; Borson Chazot F; Tilikete C; Jouanneau E; Raverot G
Endocrine; 2021 Jan; 71(1):168-177. PubMed ID: 32959228
[TBL] [Abstract][Full Text] [Related]
2. Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom.
Bujawansa S; Thondam SK; Steele C; Cuthbertson DJ; Gilkes CE; Noonan C; Bleaney CW; Macfarlane IA; Javadpour M; Daousi C
Clin Endocrinol (Oxf); 2014 Mar; 80(3):419-24. PubMed ID: 23909507
[TBL] [Abstract][Full Text] [Related]
3. Comparing neuroendocrine recovery between surgical and conservative management in pituitary apoplexy patients: a propensity score-matched analysis.
Saktiwarawat K; Tunthanathip T; Oearsakul T; Taweesomboonyat C
Neurosurg Rev; 2024 May; 47(1):236. PubMed ID: 38802695
[TBL] [Abstract][Full Text] [Related]
4. Pituitary Apoplexy: Results of Surgical and Conservative Management Clinical Series and Review of the Literature.
Almeida JP; Sanchez MM; Karekezi C; Warsi N; Fernández-Gajardo R; Panwar J; Mansouri A; Suppiah S; Nassiri F; Nejad R; Kucharczyk W; Ridout R; Joaquim AF; Gentili F; Zadeh G
World Neurosurg; 2019 Oct; 130():e988-e999. PubMed ID: 31302273
[TBL] [Abstract][Full Text] [Related]
5. Management and outcomes of pituitary apoplexy.
Singh TD; Valizadeh N; Meyer FB; Atkinson JL; Erickson D; Rabinstein AA
J Neurosurg; 2015 Jun; 122(6):1450-7. PubMed ID: 25859804
[TBL] [Abstract][Full Text] [Related]
6. Pituitary apoplexy - bespoke patient management allows good clinical outcome.
Giritharan S; Gnanalingham K; Kearney T
Clin Endocrinol (Oxf); 2016 Sep; 85(3):415-22. PubMed ID: 27038242
[TBL] [Abstract][Full Text] [Related]
7. Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases.
Sibal L; Ball SG; Connolly V; James RA; Kane P; Kelly WF; Kendall-Taylor P; Mathias D; Perros P; Quinton R; Vaidya B
Pituitary; 2004; 7(3):157-163. PubMed ID: 16010459
[TBL] [Abstract][Full Text] [Related]
8. A conservative management is preferable in milder forms of pituitary tumor apoplexy.
Leyer C; Castinetti F; Morange I; Gueydan M; Oliver C; Conte-Devolx B; Dufour H; Brue T
J Endocrinol Invest; 2011; 34(7):502-9. PubMed ID: 20811169
[TBL] [Abstract][Full Text] [Related]
9. Pituitary apoplexy: how to define safe boundaries of conservative management? Early and long-term outcomes from a single UK tertiary neurosurgical unit.
Cavalli A; Martin A; Connolly DJ; Mirza S; Sinha S
Br J Neurosurg; 2021 Jun; 35(3):334-340. PubMed ID: 32870049
[TBL] [Abstract][Full Text] [Related]
10. Acute management of pituitary apoplexy--surgery or conservative management?
Ayuk J; McGregor EJ; Mitchell RD; Gittoes NJ
Clin Endocrinol (Oxf); 2004 Dec; 61(6):747-52. PubMed ID: 15579190
[TBL] [Abstract][Full Text] [Related]
11. Visual and Endocrine Recovery Following Conservative and Surgical Treatment of Pituitary Apoplexy: A Meta-Analysis.
Goshtasbi K; Abiri A; Sahyouni R; Mahboubi H; Raefsky S; Kuan EC; Hsu FPK; Cadena G
World Neurosurg; 2019 Dec; 132():33-40. PubMed ID: 31470146
[TBL] [Abstract][Full Text] [Related]
12. The Outcomes of Pituitary Apoplexy with Conservative Treatment: Experiences at a Single Institution.
Seo Y; Kim YH; Dho YS; Kim JH; Kim JW; Park CK; Kim DG
World Neurosurg; 2018 Jul; 115():e703-e710. PubMed ID: 29709755
[TBL] [Abstract][Full Text] [Related]
13. Empty Sella in the Making.
Kirigin Biloš LS; Kruljac I; Radošević JM; Ćaćić M; Škoro I; Čerina V; Pećina IH; Vrkljan M
World Neurosurg; 2019 Aug; 128():366-370. PubMed ID: 31128314
[TBL] [Abstract][Full Text] [Related]
14. Pituitary apoplexy score, toward standardized decision-making: a descriptive study.
Salle H; Cane M; Rocher M; Auditeau E; Teissier MP; Raverot G; Salle L
Pituitary; 2024 Feb; 27(1):77-87. PubMed ID: 38150169
[TBL] [Abstract][Full Text] [Related]
15. Surgical vs Nonsurgical Management for Pituitary Apoplexy.
Abucham J
J Clin Endocrinol Metab; 2024 May; 109(6):e1454-e1455. PubMed ID: 38006312
[No Abstract] [Full Text] [Related]
16. Postoperative Neurologic Outcome in Patients with Pituitary Apoplexy After Transsphenoidal Surgery.
Kim YH; Cho YH; Hong SH; Kim JH; Kim MS; Khang SK; Lee EJ; Chong K; Kim CJ
World Neurosurg; 2018 Mar; 111():e18-e23. PubMed ID: 29191540
[TBL] [Abstract][Full Text] [Related]
17. Neuro-ophthalmic manifestations and outcomes of pituitary apoplexy--a life and sight-threatening emergency.
Simon S; Torpy D; Brophy B; Blumbergs P; Selva D; Crompton JL
N Z Med J; 2011 May; 124(1335):52-9. PubMed ID: 21946682
[TBL] [Abstract][Full Text] [Related]
18. Conservative management of pituitary tumor apoplexy.
Santos AB; França MM; Hirosawa RM; Marivo M; Zanini MA; Nunes VS
Arq Bras Endocrinol Metabol; 2011 Jun; 55(5):345-8. PubMed ID: 21881818
[TBL] [Abstract][Full Text] [Related]
19. Pituitary apoplexy: retrospective review of 30 patients--is surgical intervention always necessary?
Gruber A; Clayton J; Kumar S; Robertson I; Howlett TA; Mansell P
Br J Neurosurg; 2006 Dec; 20(6):379-85. PubMed ID: 17439089
[TBL] [Abstract][Full Text] [Related]
20. Conservative treatment cures an elderly pituitary apoplexy patient with oculomotor paralysis and optic nerve compression: a case report and systematic review of the literature.
Fan Y; Bao X; Wang R
Clin Interv Aging; 2018; 13():1981-1985. PubMed ID: 30349217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
